Articles with "ebv related" as a keyword



Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection

Sign Up to like & get
recommendations!
Published in 2022 at "Medicine"

DOI: 10.1097/md.0000000000029055

Abstract: Abstract Introduction: Posttransplant lymphoproliferative disease (PTLD) is a critical complication of hematopoietic stem cell transplantation (HSCT). PTLD is classified into early and late-onset PTLDs. In post-HSCT patients, late-onset PTLD is rare, particularly PTLD after HSCT… read more here.

Keywords: ebv related; disease; ebv; epstein barr ... See more keywords

Successful Treatment of Central Nervous System Involvement in Posttransplant EBV-Related Lymphoproliferative Disease With Intrathecal Rituximab Therapy.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of pediatric hematology/oncology"

DOI: 10.1097/mph.0000000000002592

Abstract: The posttransplant lymphoproliferative disease is a severe cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Central Nervous System involvement in EBV-related PTLD is rare, and there is no standard treatment recommendation. We… read more here.

Keywords: ebv related; system involvement; central nervous; lymphoproliferative disease ... See more keywords

Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children

Sign Up to like & get
recommendations!
Published in 2024 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2024.1427637

Abstract: Background Children undergoing allo-HCT are at high risk of EBV-related complications. The objective of the study was to analyze the impact of prophylactic post-transplant rituximab on EBV infection and EBV-PTLD in children after allo-HCT, to… read more here.

Keywords: related complications; risk; ebv; ebv related ... See more keywords

Treatment Advances in EBV Related Lymphoproliferative Diseases

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.838817

Abstract: Epstein Barr virus (EBV) can affect 90% of the human population. It can invade B lymphocytes, T lymphocytes and natural killer cells of the host and remain in the host for life. The long latency… read more here.

Keywords: cell; ebv related; lymphoproliferative diseases; ebv lpds ... See more keywords